Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.07 trillion and total revenue of $110 billion.
Market Cap
1.07T
Revenue
110B
Profits
-41.26B
PE Ratio
n/a
Profit Margin
-37.51%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 107.89B | -3.04% | 1,146,471 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 61.34B | 0.38% | 1,035,747 | 14.92B |
| 3 | ARGX | argenx SE | 50.25B | -4.06% | 359,241 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.20B | -3.22% | 1,042,410 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 32.17B | -7.56% | 3,742,255 | - |
| 6 | RPRX | Royalty Pharma plc | 31.10B | -2.12% | 3,567,888 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 30.54B | -1.78% | 243,081 | 5.70B |
| 8 | BNTX | BioNTech SE | 22.54B | -2.79% | 966,896 | 3.23B |
| 9 | INSM | Insmed Incorporated | 22.48B | -2.17% | 2,406,078 | 819.56M |
| 10 | ROIV | Roivant Sciences Ltd. | 20.32B | -2.89% | 5,069,600 | 8.26M |
| 11 | INCY | Incyte Corporation | 18.43B | -3.50% | 2,021,258 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.11B | -0.91% | 5,680,120 | 2.23B |
| 13 | GMAB | Genmab A/S | 14.74B | -6.29% | 3,617,050 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 14.19B | -2.80% | 1,393,134 | 4.44B |
| 15 | ASND | Ascendis Pharma A/S | 13.45B | -1.01% | 513,839 | 998.25M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 12.51B | -2.26% | 4,697,128 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 12.20B | -3.46% | 3,037,132 | 2.38B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.06B | -3.20% | 2,081,108 | 1.06B |
| 19 | SMMT | Summit Therapeutics Inc. | 11.53B | -5.41% | 10,030,760 | - |
| 20 | AXSM | Axsome Therapeutics, Inc. | 11.43B | -3.51% | 603,784 | 708.24M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.44B | -5.90% | 374,572 | 1.13B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.31B | -3.11% | 2,708,056 | 3.24B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.98B | -5.82% | 2,009,197 | 622.01M |
| 24 | CYTK | Cytokinetics, Incorporated | 9.63B | -3.76% | 1,487,883 | 105.82M |
| 25 | KRYS | Krystal Biotech, Inc. | 8.64B | -1.64% | 334,011 | 417.30M |
| 26 | HALO | Halozyme Therapeutics, Inc. | 7.86B | -2.73% | 1,740,936 | 1.51B |
| 27 | TECH | Bio-Techne Corporation | 7.79B | -2.01% | 2,282,080 | 1.21B |
| 28 | CORT | Corcept Therapeutics Incorporated | 7.64B | 1.08% | 984,562 | 769.10M |
| 29 | IBRX | ImmunityBio, Inc. | 7.57B | -0.14% | 8,227,588 | 140.98M |
| 30 | NUVL | Nuvalent, Inc. | 7.22B | -1.78% | 1,723,111 | - |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 7.19B | -23.00% | 1,549,640 | 7.46M |
| 32 | PCVX | Vaxcyte, Inc. | 6.85B | -3.07% | 1,113,968 | - |
| 33 | LEGN | Legend Biotech Corporation | 6.74B | 42.22% | 14,661,821 | 1.14B |
| 34 | IMVT | Immunovant, Inc. | 6.35B | -5.90% | 1,926,454 | - |
| 35 | CNTA | Centessa Pharmaceuticals plc | 6.18B | 0.15% | 1,118,774 | 15.00M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 6.01B | -1.96% | 800,139 | - |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.00B | -1.78% | 720,162 | 74.06M |
| 38 | APGE | Apogee Therapeutics, Inc. | 5.90B | -0.67% | 1,113,648 | - |
| 39 | KYMR | Kymera Therapeutics, Inc. | 5.86B | -9.15% | 836,939 | 51.48M |
| 40 | ABVX | ABIVAX Société Anonyme | 5.86B | -44.10% | 16,096,028 | 5.67M |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.78B | -4.01% | 524,717 | 217.17M |
| 42 | PTCT | PTC Therapeutics, Inc. | 5.66B | -7.55% | 1,238,231 | 827.11M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 5.62B | -4.32% | 661,212 | 569.61M |
| 44 | COGT | Cogent Biosciences, Inc. | 5.60B | -5.89% | 4,266,944 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.35B | -5.72% | 1,104,784 | - |
| 46 | BLTE | Belite Bio, Inc | 5.31B | -8.21% | 391,038 | - |
| 47 | TGTX | TG Therapeutics, Inc. | 5.19B | -2.06% | 1,528,243 | 700.35M |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.06B | -2.08% | 1,899,539 | 7.50M |
| 49 | CRSP | CRISPR Therapeutics AG | 5.02B | -4.00% | 1,367,024 | 4.10M |
| 50 | CGON | CG Oncology, Inc. | 4.90B | -6.25% | 1,164,640 | 5.07M |
| 51 | CAI | Caris Life Sciences, Inc. | 4.67B | 0.43% | 2,527,019 | 907.29M |
| 52 | LGND | Ligand Pharmaceuticals Incorporated | 4.67B | 1.35% | 185,122 | 274.48M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.46B | -8.81% | 803,090 | 1.34M |
| 54 | CELC | Celcuity Inc. | 4.46B | -25.65% | 5,683,969 | - |
| 55 | ERAS | Erasca, Inc. | 4.19B | -2.46% | 7,127,297 | - |
| 56 | MANE | Veradermics, Incorporated | 4.10B | -3.28% | 424,802 | - |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.01B | -7.48% | 2,792,754 | - |
| 58 | TVTX | Travere Therapeutics, Inc. | 3.99B | -4.62% | 2,533,694 | 536.20M |
| 59 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | - | 1,004,227 | 596.96M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.71B | -0.25% | 1,155,780 | 22.57M |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.58B | -2.93% | 1,235,977 | 1.10B |
| 62 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.44B | -5.53% | 978,146 | 18.07M |
| 63 | RLAY | Relay Therapeutics, Inc. | 3.42B | 10.10% | 11,482,124 | 10.68M |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.40B | -6.33% | 2,754,181 | - |
| 65 | ORKA | Oruka Therapeutics, Inc. | 3.33B | 0.40% | 1,161,416 | - |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.11B | -6.93% | 3,184,906 | 56.99M |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.08B | -2.76% | 186,235 | 803.79M |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.08B | -4.67% | 1,178,386 | 236.00M |
| 69 | DNLI | Denali Therapeutics Inc. | 3.07B | -5.19% | 1,754,647 | - |
| 70 | KLRA | Kailera Therapeutics, Inc. | 2.97B | -1.16% | 443,625 | - |
| 71 | BEAM | Beam Therapeutics Inc. | 2.88B | -7.00% | 1,768,823 | 164.01M |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.85B | -7.46% | 1,881,578 | - |
| 73 | GPCR | Structure Therapeutics Inc. | 2.64B | -3.53% | 853,965 | - |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 2.60B | -3.17% | 2,310,891 | 415.62M |
| 75 | IRON | Disc Medicine, Inc. | 2.60B | -5.52% | 415,536 | - |
| 76 | ALMS | Alumis Inc. | 2.55B | -1.43% | 975,382 | 8.40M |
| 77 | DFTX | Definium Therapeutics, Inc. | 2.49B | -4.99% | 2,272,469 | - |
| 78 | TARS | Tarsus Pharmaceuticals, Inc. | 2.47B | -2.72% | 877,943 | 535.08M |
| 79 | IDYA | IDEAYA Biosciences, Inc. | 2.45B | -3.70% | 948,103 | 225.27M |
| 80 | MLYS | Mineralys Therapeutics, Inc. | 2.38B | -7.26% | 728,549 | - |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.27B | -4.11% | 918,408 | 865.00K |
| 82 | VERA | Vera Therapeutics, Inc. | 2.24B | -7.90% | 1,184,633 | - |
| 83 | IMNM | Immunome, Inc. | 2.19B | -6.93% | 2,605,442 | 4.02M |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.16B | -5.31% | 1,496,552 | - |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.14B | -4.68% | 2,029,030 | 670.00M |
| 86 | KOD | Kodiak Sciences Inc. | 2.07B | -10.01% | 836,888 | - |
| 87 | PHVS | Pharvaris N.V. | 2.02B | -0.41% | 349,741 | - |
| 88 | AUPH | Aurinia Pharmaceuticals Inc. | 1.98B | 0.52% | 1,096,995 | 298.30M |
| 89 | NKTR | Nektar Therapeutics | 1.98B | -8.30% | 2,069,486 | 55.63M |
| 90 | ZLAB | Zai Lab Limited | 1.93B | 0.37% | 1,768,803 | 453.28M |
| 91 | TRVI | Trevi Therapeutics, Inc. | 1.92B | -3.23% | 925,777 | - |
| 92 | RXRX | Recursion Pharmaceuticals, Inc. | 1.92B | -4.75% | 20,718,080 | 66.41M |
| 93 | MESO | Mesoblast Limited | 1.91B | -2.29% | 178,465 | 65.38M |
| 94 | ABCL | AbCellera Biologics Inc. | 1.87B | -5.11% | 7,736,678 | 79.21M |
| 95 | NBTX | Nanobiotix S.A. | 1.85B | -3.53% | 53,919 | 38.27M |
| 96 | NTLA | Intellia Therapeutics, Inc. | 1.83B | -4.37% | 3,603,601 | 66.09M |
| 97 | IOVA | Iovance Biotherapeutics, Inc. | 1.83B | 3.54% | 12,689,147 | 285.61M |
| 98 | OCUL | Ocular Therapeutix, Inc. | 1.82B | -6.94% | 2,714,408 | 52.04M |
| 99 | LKFT | Lakefront Biotherapeutics NV | 1.82B | -0.84% | 303,524 | 1.20B |
| 100 | HRMY | Harmony Biosciences Holdings, Inc. | 1.79B | -2.84% | 1,076,821 | 899.11M |
| 101 | STOK | Stoke Therapeutics, Inc. | 1.79B | -5.87% | 600,157 | 32.08M |
| 102 | ATAI | AtaiBeckley Inc. | 1.76B | -0.21% | 6,684,884 | 3.49M |
| 103 | ADMA | ADMA Biologics, Inc. | 1.76B | -3.80% | 3,270,196 | 509.86M |
| 104 | VCEL | Vericel Corporation | 1.76B | 4.95% | 940,700 | 292.09M |
| 105 | ZYME | Zymeworks Inc. | 1.76B | -1.96% | 533,090 | 81.26M |
| 106 | VRDN | Viridian Therapeutics, Inc. | 1.75B | -6.43% | 2,408,636 | 70.92M |
| 107 | SRPT | Sarepta Therapeutics, Inc. | 1.72B | -7.72% | 3,656,635 | 2.18B |
| 108 | AAPG | Ascentage Pharma Group International | 1.71B | -3.30% | 2,049 | 82.08M |
| 109 | GHRS | GH Research PLC | 1.71B | 0.16% | 381,566 | - |
| 110 | NUVB | Nuvation Bio Inc. | 1.71B | -1.21% | 3,881,499 | 143.05M |
| 111 | TYRA | Tyra Biosciences, Inc. | 1.70B | -5.69% | 716,748 | - |
| 112 | NRIX | Nurix Therapeutics, Inc. | 1.69B | -5.87% | 1,050,537 | 71.78M |
| 113 | QURE | uniQure N.V. | 1.69B | -5.17% | 886,526 | 18.09M |
| 114 | NVAX | Novavax, Inc. | 1.68B | -2.85% | 4,340,143 | 596.34M |
| 115 | RAPP | Rapport Therapeutics, Inc. | 1.67B | -5.96% | 309,381 | 20.00M |
| 116 | SION | Sionna Therapeutics, Inc. | 1.65B | -10.81% | 515,504 | - |
| 117 | TSHA | Taysha Gene Therapies, Inc. | 1.64B | -4.69% | 1,545,000 | 7.47M |
| 118 | SNDX | Syndax Pharmaceuticals, Inc. | 1.63B | -2.44% | 1,337,177 | 217.17M |
| 119 | CAPR | Capricor Therapeutics, Inc. | 1.58B | -4.17% | 768,044 | 11.13M |
| 120 | AGIO | Agios Pharmaceuticals, Inc. | 1.58B | -5.32% | 892,877 | 66.05M |
| 121 | INVA | Innoviva, Inc. | 1.58B | -0.74% | 1,047,117 | 420.69M |
| 122 | SLS | SELLAS Life Sciences Group, Inc. | 1.55B | -8.16% | 10,279,533 | - |
| 123 | GENB | Generate Biomedicines, Inc. | 1.53B | -7.71% | 1,213,704 | 30.30M |
| 124 | BHVN | Biohaven Ltd. | 1.53B | -11.37% | 2,079,057 | - |
| 125 | IMCR | Immunocore Holdings plc | 1.51B | 1.73% | 599,846 | 412.81M |
| 126 | PVLA | Palvella Therapeutics, Inc. | 1.50B | -7.03% | 200,402 | - |
| 127 | GLUE | Monte Rosa Therapeutics, Inc. | 1.50B | -9.81% | 972,488 | 42.95M |
| 128 | ANAB | AnaptysBio, Inc. | 1.49B | -3.54% | 819,848 | 232.39M |
| 129 | VIR | Vir Biotechnology, Inc. | 1.47B | -3.21% | 1,408,925 | 65.50M |
| 130 | MBX | MBX Biosciences, Inc. | 1.46B | 0.16% | 609,313 | - |
| 131 | FTRE | Fortrea Holdings Inc. | 1.45B | -2.54% | 1,372,371 | 2.71B |
| 132 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | - | 1,394,458 | 114.48M |
| 133 | DMRA | Damora Therapeutics, Inc. | 1.41B | -7.65% | 288,657 | - |
| 134 | AVBP | ArriVent BioPharma, Inc. | 1.39B | -2.48% | 794,920 | - |
| 135 | PGEN | Precigen, Inc. | 1.38B | -6.31% | 6,911,798 | 31.60M |
| 136 | INBX | Inhibrx Biosciences, Inc. | 1.37B | -5.96% | 320,639 | 1.30M |
| 137 | ARDX | Ardelyx, Inc. | 1.36B | -3.66% | 4,148,391 | 427.68M |
| 138 | SEPN | Septerna, Inc. | 1.35B | -0.20% | 603,614 | 72.26M |
| 139 | IMTX | Immatics N.V. | 1.35B | -9.87% | 2,115,198 | 43.00M |
| 140 | MAZE | Maze Therapeutics, Inc. | 1.34B | -4.60% | 285,773 | 20.00M |
| 141 | SVRA | Savara Inc. | 1.33B | 1.94% | 1,935,896 | - |
| 142 | MLTX | MoonLake Immunotherapeutics | 1.32B | -5.05% | 1,118,769 | - |
| 143 | URGN | UroGen Pharma Ltd. | 1.29B | -1.81% | 727,141 | 140.49M |
| 144 | BCAX | Bicara Therapeutics Inc. | 1.29B | -4.75% | 669,224 | - |
| 145 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.25B | 1.68% | 2,251,439 | 204.73M |
| 146 | MPLT | MapLight Therapeutics, Inc. | 1.24B | -8.13% | 467,773 | - |
| 147 | COAG | Hemab Therapeutics Holdings, Inc. | 1.21B | 1.25% | 194,536 | - |
| 148 | AKTS | Aktis Oncology, Inc. | 1.12B | 4.00% | 310,061 | 8.28M |
| 149 | WVE | Wave Life Sciences Ltd. | 1.09B | -9.11% | 4,297,932 | 71.80M |
| 150 | ZBIO | Zenas BioPharma, Inc. | 1.08B | -5.72% | 632,553 | 10.00M |
| 151 | AVLN | Avalyn Pharma Inc. | 1.08B | -3.53% | 149,939 | - |
| 152 | MNKD | MannKind Corporation | 1.06B | -2.83% | 7,012,045 | 360.78M |
| 153 | DBVT | DBV Technologies S.A. | 1.05B | -3.03% | 251,662 | 5.74M |
| 154 | EYPT | EyePoint, Inc. | 1.05B | -4.71% | 991,293 | 7.61M |
| 155 | ABSI | Absci Corporation | 990.00M | -2.61% | 3,421,751 | 1.84M |
| 156 | CRVS | Corvus Pharmaceuticals, Inc. | 983.02M | -3.23% | 1,911,741 | - |
| 157 | CGEM | Cullinan Therapeutics, Inc. | 947.99M | -4.84% | 1,290,345 | - |
| 158 | OLMA | Olema Pharmaceuticals, Inc. | 933.74M | -15.89% | 2,737,099 | - |
| 159 | SPTX | Seaport Therapeutics, Inc. | 912.61M | 0.47% | 87,644 | - |
| 160 | SANA | Sana Biotechnology, Inc. | 901.66M | 0.93% | 2,215,587 | - |
| 161 | PHAR | Pharming Group N.V. | 884.46M | -4.73% | 22,566 | 369.49M |
| 162 | SPRY | ARS Pharmaceuticals, Inc. | 883.80M | -5.62% | 1,853,304 | 98.99M |
| 163 | JBIO | Jade Biosciences, Inc. | 876.14M | -4.52% | 993,324 | - |
| 164 | ANNX | Annexon, Inc. | 861.81M | -5.73% | 2,102,472 | - |
| 165 | MGTX | MeiraGTx Holdings plc | 855.71M | -5.71% | 790,893 | 79.76M |
| 166 | ABUS | Arbutus Biopharma Corporation | 841.51M | -4.91% | 1,750,124 | 191.45M |
| 167 | JANX | Janux Therapeutics, Inc. | 840.36M | -4.37% | 704,370 | 13.73M |
| 168 | LXRX | Lexicon Pharmaceuticals, Inc. | 839.53M | -8.70% | 3,156,378 | 69.64M |
| 169 | XNCR | Xencor, Inc. | 831.13M | -5.00% | 595,388 | 97.36M |
| 170 | IVA | Inventiva S.A. | 829.57M | -14.26% | 2,600,178 | 7.94M |
| 171 | DRTS | Alpha Tau Medical Ltd. | 805.27M | -7.60% | 1,074,188 | - |
| 172 | TBPH | Theravance Biopharma, Inc. | 803.20M | -2.26% | 814,822 | 109.78M |
| 173 | ODTX | Odyssey Therapeutics, Inc. | 799.60M | -0.06% | 436,781 | 2.98M |
| 174 | KURA | Kura Oncology, Inc. | 796.31M | -0.72% | 2,658,662 | 71.64M |
| 175 | ORIC | ORIC Pharmaceuticals, Inc. | 788.80M | -15.14% | 4,018,990 | - |
| 176 | LBRX | LB Pharmaceuticals Inc | 774.84M | -3.60% | 147,290 | - |
| 177 | PHAT | Phathom Pharmaceuticals, Inc. | 766.50M | 4.44% | 1,649,425 | 204.89M |
| 178 | AURA | Aura Biosciences, Inc. | 761.07M | -4.03% | 442,003 | - |
| 179 | DRUG | Bright Minds Biosciences Inc. | 757.92M | -5.23% | 508,382 | - |
| 180 | GERN | Geron Corporation | 750.58M | -3.31% | 13,018,412 | 196.12M |
| 181 | OMER | Omeros Corporation | 742.57M | -4.29% | 1,178,146 | 9.89M |
| 182 | OCS | Oculis Holding AG | 742.17M | -15.30% | 3,107,396 | 1.40M |
| 183 | VOR | Vor Biopharma Inc. | 740.18M | -6.25% | 556,195 | - |
| 184 | AVTX | Avalo Therapeutics, Inc. | 733.82M | -11.37% | 1,604,167 | 59.00K |
| 185 | REPL | Replimune Group, Inc. | 732.42M | -1.44% | 3,791,595 | - |
| 186 | EVMN | Evommune, Inc. | 713.88M | -10.60% | 387,725 | 10.00M |
| 187 | ALLO | Allogene Therapeutics, Inc. | 707.57M | -4.65% | 7,364,776 | 22.00K |
| 188 | CTMX | CytomX Therapeutics, Inc. | 687.94M | -8.41% | 4,923,848 | 35.54M |
| 189 | RLMD | Relmada Therapeutics, Inc. | 673.40M | -6.28% | 1,909,609 | - |
| 190 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 659.28M | -3.74% | 135,439 | - |
| 191 | ANRO | Alto Neuroscience, Inc. | 655.84M | -5.51% | 321,145 | - |
| 192 | SLDB | Solid Biosciences Inc. | 647.80M | -8.48% | 1,097,377 | - |
| 193 | ACRS | Aclaris Therapeutics, Inc. | 646.64M | 6.68% | 1,510,153 | 8.37M |
| 194 | TENX | Tenax Therapeutics, Inc. | 644.72M | -8.52% | 879,912 | - |
| 195 | ZVRA | Zevra Therapeutics, Inc. | 643.17M | -5.31% | 1,539,084 | 122.29M |
| 196 | CRMD | CorMedix Inc. | 640.95M | -3.31% | 956,690 | 400.05M |
| 197 | DSGN | Design Therapeutics, Inc. | 635.19M | -2.59% | 1,052,617 | - |
| 198 | CADL | Candel Therapeutics, Inc. | 616.94M | -1.06% | 1,719,756 | - |
| 199 | SGP | SpyGlass Pharma, Inc. | 613.71M | 0.22% | 44,918 | - |
| 200 | DNA | Ginkgo Bioworks Holdings, Inc. | 609.48M | 2.08% | 2,715,227 | 151.40M |
| 201 | CABA | Cabaletta Bio, Inc. | 600.04M | 0.27% | 3,438,611 | - |
| 202 | IMMX | Immix Biopharma, Inc. | 583.80M | -9.27% | 1,337,380 | - |
| 203 | PRME | Prime Medicine, Inc. | 579.78M | -5.59% | 3,092,052 | 4.03M |
| 204 | AGMB | AgomAb Therapeutics NV | 579.65M | 2.88% | 51,887 | - |
| 205 | PROK | ProKidney Corp. | 573.91M | 2.70% | 2,214,821 | 889.00K |
| 206 | CBIO | Crescent Biopharma, Inc. | 565.06M | -13.77% | 437,081 | 11.88M |
| 207 | ALT | Altimmune, Inc. | 563.98M | -3.65% | 1,942,548 | 36.00K |
| 208 | TRAX | First Tracks Biotherapeutics, Inc. | 563.16M | -10.78% | 711,557 | - |
| 209 | RIGL | Rigel Pharmaceuticals, Inc. | 555.43M | 0.54% | 405,742 | 299.77M |
| 210 | CLYM | Climb Bio, Inc. | 535.01M | -5.08% | 1,370,188 | - |
| 211 | MDXG | MiMedx Group, Inc. | 531.74M | -0.28% | 1,173,744 | 389.42M |
| 212 | VALN | Valneva SE | 528.88M | -5.38% | 38,628 | 180.25M |
| 213 | XOMA | XOMA Royalty Corporation | 522.84M | - | 79,459 | 48.56M |
| 214 | EIKN | Eikon Therapeutics, Inc. | 519.46M | -11.08% | 219,613 | - |
| 215 | TECX | Tectonic Therapeutic, Inc. | 517.58M | -5.05% | 173,957 | - |
| 216 | ACHV | Achieve Life Sciences, Inc. | 516.38M | -5.09% | 824,911 | - |
| 217 | ARVN | Arvinas, Inc. | 516.17M | -6.76% | 845,005 | 89.40M |
| 218 | GYRE | Gyre Therapeutics, Inc. | 508.94M | -4.13% | 120,656 | 117.05M |
| 219 | ASMB | Assembly Biosciences, Inc. | 485.32M | -9.03% | 276,588 | 71.10M |
| 220 | FDMT | 4D Molecular Therapeutics, Inc. | 484.60M | -4.53% | 895,172 | 88.24M |
| 221 | PRTA | Prothena Corporation plc | 481.13M | -4.17% | 290,842 | 57.94M |
| 222 | KYTX | Kyverna Therapeutics, Inc. | 478.19M | -3.89% | 1,548,464 | - |
| 223 | CCCC | C4 Therapeutics, Inc. | 478.18M | -0.91% | 4,005,634 | 34.86M |
| 224 | AUTL | Autolus Therapeutics plc | 465.75M | -4.89% | 1,166,661 | 92.62M |
| 225 | CTNM | Contineum Therapeutics, Inc. | 465.09M | -4.97% | 242,288 | - |
| 226 | ANL | Adlai Nortye Ltd. | 463.20M | -3.74% | 71,721 | 5.00M |
| 227 | OCGN | Ocugen, Inc. | 453.62M | -2.19% | 4,058,471 | 4.47M |
| 228 | EPRX | Eupraxia Pharmaceuticals Inc. | 452.03M | -3.06% | 296,506 | - |
| 229 | OVID | Ovid Therapeutics Inc. | 447.94M | -6.25% | 1,372,544 | 7.12M |
| 230 | FBRX | Forte Biosciences, Inc. | 444.12M | -5.54% | 322,853 | - |
| 231 | EDIT | Editas Medicine, Inc. | 432.76M | -15.57% | 3,840,329 | 38.69M |
| 232 | CNXU | Conexeu Sciences Inc. | 425.55M | 19.26% | 286,279 | - |
| 233 | SGMT | Sagimet Biosciences Inc. | 419.29M | -5.56% | 923,475 | - |
| 234 | RZLT | Rezolute, Inc. | 417.87M | 10.80% | 6,725,793 | - |
| 235 | NGNE | Neurogene Inc. | 413.06M | -5.08% | 107,357 | 925.00K |
| 236 | VTVT | vTv Therapeutics Inc. | 409.45M | -3.80% | 24,091 | 36.84M |
| 237 | MNPR | Monopar Therapeutics Inc. | 408.56M | -5.30% | 103,129 | - |
| 238 | STRO | Sutro Biopharma, Inc. | 404.82M | -13.52% | 332,360 | 99.61M |
| 239 | ADCT | ADC Therapeutics SA | 403.20M | -6.76% | 672,047 | 79.18M |
| 240 | UPB | Upstream Bio, Inc. | 394.54M | -10.27% | 632,055 | 3.32M |
| 241 | IPSC | Century Therapeutics, Inc. | 391.37M | -8.05% | 1,146,896 | 109.16M |
| 242 | ZURA | Zura Bio Limited | 389.01M | -3.30% | 646,960 | - |
| 243 | XFOR | X4 Pharmaceuticals, Inc. | 381.99M | -1.46% | 475,268 | 9.01M |
| 244 | OABI | OmniAb, Inc. | 379.83M | 0.38% | 757,346 | 28.94M |
| 245 | CMPX | Compass Therapeutics, Inc. | 374.58M | -6.31% | 5,181,693 | 850.00K |
| 246 | STTK | Shattuck Labs, Inc. | 373.43M | -13.81% | 640,219 | 1.00M |
| 247 | VNDA | Vanda Pharmaceuticals Inc. | 368.63M | -3.69% | 926,620 | 217.78M |
| 248 | BNTC | Benitec Biopharma Inc. | 363.47M | -2.22% | 96,553 | - |
| 249 | GLSI | Greenwich LifeSciences, Inc. | 356.53M | -14.80% | 476,600 | - |
| 250 | PBYI | Puma Biotechnology, Inc. | 355.28M | -1.97% | 330,850 | 227.18M |
| 251 | LXEO | Lexeo Therapeutics, Inc. | 354.13M | -6.24% | 702,190 | - |
| 252 | ENTA | Enanta Pharmaceuticals, Inc. | 348.94M | -5.29% | 196,987 | 69.21M |
| 253 | LYEL | Lyell Immunopharma, Inc. | 347.44M | -13.18% | 87,739 | 31.00K |
| 254 | PRLD | Prelude Therapeutics Incorporated | 346.13M | -8.64% | 374,195 | 16.72M |
| 255 | FENC | Fennec Pharmaceuticals Inc. | 345.46M | 0.66% | 351,331 | 51.00M |
| 256 | LRMR | Larimar Therapeutics, Inc. | 344.46M | -5.98% | 1,696,141 | - |
| 257 | AVIR | Atea Pharmaceuticals, Inc. | 341.72M | -2.51% | 312,411 | - |
| 258 | NAUT | Nautilus Biotechnology, Inc. | 340.57M | -3.25% | 559,768 | - |
| 259 | RGNX | REGENXBIO Inc. | 337.07M | -8.68% | 1,641,763 | 87.82M |
| 260 | IVVD | Invivyd, Inc. | 335.85M | -6.56% | 1,819,437 | 55.87M |
| 261 | VSTM | Verastem, Inc. | 334.80M | -9.07% | 3,431,055 | 49.59M |
| 262 | ARTV | Artiva Biotherapeutics, Inc. | 333.80M | -7.91% | 591,493 | 251.00K |
| 263 | ABEO | Abeona Therapeutics Inc. | 324.30M | 1.07% | 815,972 | 14.54M |
| 264 | NMRA | Neumora Therapeutics, Inc. | 320.62M | -3.57% | 838,933 | - |
| 265 | IFRX | InflaRx N.V. | 319.63M | -4.82% | 1,446,084 | 33.82K |
| 266 | RCKT | Rocket Pharmaceuticals, Inc. | 315.57M | -4.30% | 3,575,445 | - |
| 267 | PALI | Palisade Bio, Inc. | 311.41M | -10.58% | 5,163,717 | - |
| 268 | DMAC | DiaMedica Therapeutics Inc. | 310.91M | -1.20% | 152,424 | - |
| 269 | HUMA | Humacyte, Inc. | 308.61M | -4.14% | 8,559,216 | 2.02M |
| 270 | SLN | Silence Therapeutics plc | 301.83M | -2.14% | 193,045 | 839.00K |
| 271 | LCTX | Lineage Cell Therapeutics, Inc. | 301.65M | -3.97% | 1,689,421 | 14.78M |
| 272 | BCYC | Bicycle Therapeutics plc | 300.54M | -4.97% | 320,145 | 63.50M |
| 273 | FATE | Fate Therapeutics, Inc. | 299.56M | -6.20% | 2,920,555 | 6.32M |
| 274 | ARMP | Armata Pharmaceuticals, Inc. | 290.63M | 1.54% | 37,045 | 5.20M |
| 275 | IKT | Inhibikase Therapeutics, Inc. | 289.72M | -0.58% | 474,907 | 1.00 |
| 276 | IRD | Opus Genetics, Inc. | 284.90M | -3.16% | 823,574 | 11.98M |
| 277 | NAGE | Niagen Bioscience, Inc. | 282.53M | -1.94% | 812,331 | 130.42M |
| 278 | ZNTL | Zentalis Pharmaceuticals, Inc. | 281.19M | -0.75% | 1,668,203 | 26.87M |
| 279 | IMRX | Immuneering Corporation | 276.90M | -4.78% | 2,420,411 | - |
| 280 | ELDN | Eledon Pharmaceuticals, Inc. | 272.88M | -6.12% | 942,549 | - |
| 281 | SRZN | Surrozen, Inc. | 269.24M | -6.15% | 122,556 | 7.49M |
| 282 | AVXL | Anavex Life Sciences Corp. | 258.09M | -6.54% | 1,659,171 | - |
| 283 | MGNX | MacroGenics, Inc. | 257.42M | -2.17% | 492,448 | 157.08M |
| 284 | NVCT | Nuvectis Pharma, Inc. | 252.26M | -2.46% | 76,116 | - |
| 285 | CLLS | Cellectis S.A. | 249.39M | -2.87% | 46,857 | 75.11M |
| 286 | SABS | SAB Biotherapeutics, Inc. | 244.56M | 1.16% | 432,248 | 114.70K |
| 287 | CDXS | Codexis, Inc. | 244.51M | 0.75% | 505,763 | 78.09M |
| 288 | TARA | Protara Therapeutics, Inc. | 243.93M | -3.98% | 510,847 | - |
| 289 | INDP | Indaptus Therapeutics, Inc. | 243.47M | 11.98% | 107,002 | - |
| 290 | SLGL | Sol-Gel Technologies Ltd. | 241.02M | 4.73% | 13,080 | 18.47M |
| 291 | ACIU | AC Immune SA | 240.07M | -1.63% | 545,939 | 4.62M |
| 292 | ALXO | ALX Oncology Holdings Inc. | 239.52M | -1.11% | 858,749 | - |
| 293 | TRDA | Entrada Therapeutics, Inc. | 239.26M | -3.91% | 298,978 | 5.74M |
| 294 | CHRS | Coherus Oncology, Inc. | 234.46M | -3.18% | 894,824 | 46.88M |
| 295 | OBIO | Orchestra BioMed Holdings, Inc. | 234.13M | 2.09% | 177,617 | 32.72M |
| 296 | CRBU | Caribou Biosciences, Inc. | 230.10M | -4.53% | 1,737,515 | 11.20M |
| 297 | HELP | Cybin Inc. | 227.66M | -2.99% | 765,895 | - |
| 298 | ADAG | Adagene Inc. | 224.65M | -10.05% | 175,222 | 7.67M |
| 299 | YDES | YD Bio Limited | 224.32M | 4.08% | 27,252 | 510.36K |
| 300 | LENZ | LENZ Therapeutics, Inc. | 223.56M | -4.17% | 626,714 | 20.99M |
| 301 | CNTX | Context Therapeutics Inc. | 222.35M | -13.26% | 538,138 | - |
| 302 | NERV | Minerva Neurosciences, Inc. | 221.30M | -1.86% | 197,547 | - |
| 303 | ARCT | Arcturus Therapeutics Holdings Inc. | 217.44M | -1.54% | 466,358 | 54.71M |
| 304 | VYGR | Voyager Therapeutics, Inc. | 216.91M | -5.15% | 631,193 | 36.49M |
| 305 | ALEC | Alector, Inc. | 216.50M | -5.80% | 1,561,015 | 18.42M |
| 306 | QTTB | Q32 Bio Inc. | 214.33M | 8.40% | 777,131 | 53.74M |
| 307 | CGEN | Compugen Ltd. | 213.76M | -8.13% | 1,117,396 | 72.66M |
| 308 | FHTX | Foghorn Therapeutics Inc. | 213.13M | -8.68% | 230,378 | 28.22M |
| 309 | NGEN | NervGen Pharma Corp. | 212.41M | 3.09% | 623,370 | - |
| 310 | ELTX | Elicio Therapeutics, Inc. | 210.54M | -5.57% | 122,114 | - |
| 311 | RNA | Atrium Therapeutics, Inc. | 209.54M | -3.39% | 180,681 | 36.68M |
| 312 | FULC | Fulcrum Therapeutics, Inc. | 209.23M | -51.09% | 32,776,683 | 80.00M |
| 313 | KROS | Keros Therapeutics, Inc. | 208.80M | -3.21% | 310,724 | 33.18M |
| 314 | KPTI | Karyopharm Therapeutics Inc. | 208.37M | -5.91% | 525,467 | 151.12M |
| 315 | NKTX | Nkarta, Inc. | 208.20M | -7.32% | 442,755 | - |
| 316 | WHWK | Whitehawk Therapeutics, Inc. | 206.61M | -6.90% | 218,152 | 7.15M |
| 317 | CAMP | Camp4 Therapeutics Corporation | 206.15M | -1.73% | 88,545 | 3.93M |
| 318 | ENLV | Enlivex Ltd. | 204.87M | -1.56% | 701,721 | - |
| 319 | IMUX | Immunic, Inc. | 199.42M | -3.24% | 246,418 | - |
| 320 | NBP | NovaBridge Biosciences | 197.76M | - | 409,405 | - |
| 321 | UNCY | Unicycive Therapeutics, Inc. | 193.04M | -4.87% | 901,034 | - |
| 322 | RNAC | Cartesian Therapeutics, Inc. | 188.34M | -7.37% | 142,178 | 1.78M |
| 323 | TTRX | Turn Therapeutics Inc. | 187.37M | -0.63% | 74,621 | - |
| 324 | TNXP | Tonix Pharmaceuticals Holding Corp. | 186.83M | -4.64% | 739,785 | 17.56M |
| 325 | MIST | Milestone Pharmaceuticals Inc. | 179.59M | -2.94% | 1,198,493 | 1.78M |
| 326 | MDWD | MediWound Ltd. | 176.85M | -0.43% | 111,652 | 14.48M |
| 327 | EQ | Equillium, Inc. | 176.40M | -9.42% | 2,734,941 | 4.39M |
| 328 | TLSA | Tiziana Life Sciences Ltd | 175.86M | -2.86% | 167,610 | - |
| 329 | TNYA | Tenaya Therapeutics, Inc. | 171.43M | -9.20% | 5,609,952 | 225.00K |
| 330 | ABOS | Acumen Pharmaceuticals, Inc. | 171.18M | -5.58% | 265,866 | - |
| 331 | IPHA | Innate Pharma S.A. | 171.10M | 2.25% | 38,521 | 10.57M |
| 332 | OKUR | OnKure Therapeutics, Inc. | 170.47M | 0.48% | 416,992 | - |
| 333 | NRXP | NRx Pharmaceuticals, Inc. | 167.23M | - | 2,107,424 | 2.29M |
| 334 | SPRO | Spero Therapeutics, Inc. | 163.86M | - | 582,629 | 61.19M |
| 335 | DTIL | Precision BioSciences, Inc. | 163.07M | -9.97% | 461,554 | 45.07M |
| 336 | MENS | Jyong Biotech Ltd. | 160.34M | 4.85% | 125,144 | - |
| 337 | PLX | Protalix BioTherapeutics, Inc. | 160.34M | -3.40% | 537,240 | 76.38M |
| 338 | GALT | Galectin Therapeutics Inc. | 159.37M | -7.28% | 279,005 | - |
| 339 | KRRO | Korro Bio, Inc. | 158.65M | -14.93% | 156,576 | 3.84M |
| 340 | PRQR | ProQR Therapeutics N.V. | 154.88M | 3.52% | 713,782 | 15.73M |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 147.33M | -7.46% | 394,576 | 2.00M |
| 342 | ANTX | AN2 Therapeutics, Inc. | 146.50M | -3.33% | 176,448 | - |
| 343 | MOLN | Molecular Partners AG | 143.12M | -0.76% | 6,279 | 856.30K |
| 344 | AGEN | Agenus Inc. | 140.40M | -2.87% | 385,051 | 123.87M |
| 345 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 139.70M | -2.71% | 835,666 | - |
| 346 | HURA | TuHURA Biosciences, Inc. | 138.83M | -2.68% | 300,475 | - |
| 347 | CNTB | Connect Biopharma Holdings Limited | 135.37M | -8.12% | 223,809 | 233.00K |
| 348 | KZIA | Kazia Therapeutics Limited | 134.72M | -6.13% | 300,561 | 1.27M |
| 349 | ACOG | Alpha Cognition Inc. | 134.56M | -2.52% | 14,917 | 10.83M |
| 350 | CNTN | Canton Strategic Holdings, Inc. | 134.28M | -15.51% | 2,566,449 | - |
| 351 | SPRB | Spruce Biosciences, Inc. | 133.22M | -2.76% | 31,013 | 697.00K |
| 352 | GNLX | Genelux Corporation | 131.01M | -0.67% | 139,978 | 8.00K |
| 353 | GUTS | Fractyl Health, Inc. | 125.29M | -8.94% | 1,026,623 | 3.00K |
| 354 | PLYX | Polaryx Therapeutics, Inc. | 124.99M | -5.71% | 540,512 | - |
| 355 | BDTX | Black Diamond Therapeutics, Inc. | 124.92M | -3.54% | 927,730 | 70.00M |
| 356 | CGTX | Cognition Therapeutics, Inc. | 120.63M | 8.00% | 2,892,592 | - |
| 357 | ENGN | enGene Therapeutics Inc. | 116.56M | -2.25% | 937,087 | - |
| 358 | NTHI | NeOnc Technologies Holdings, Inc. | 115.95M | 0.88% | 69,628 | 39.99K |
| 359 | ALPS | Alps Group Inc | 115.17M | -5.19% | 21,350 | 3.74M |
| 360 | VANI | Vivani Medical, Inc. | 112.11M | 0.78% | 216,030 | - |
| 361 | COYA | Coya Therapeutics, Inc. | 110.95M | -3.67% | 201,422 | 7.94M |
| 362 | PYXS | Pyxis Oncology, Inc. | 108.34M | -4.47% | 479,738 | 13.86M |
| 363 | ONCY | Oncolytics Biotech Inc. | 107.72M | -12.49% | 2,792,056 | - |
| 364 | KLRS | Kalaris Therapeutics, Inc. | 106.91M | -5.10% | 99,783 | - |
| 365 | CBUS | Cibus, Inc. | 106.41M | -5.10% | 323,600 | 3.64M |
| 366 | SEER | Seer, Inc. | 105.51M | -0.53% | 79,310 | 16.58M |
| 367 | CRDF | Cardiff Oncology, Inc. | 103.24M | 2.03% | 2,687,526 | 525.00K |
| 368 | PEPG | PepGen Inc. | 100.30M | -1.36% | 665,559 | - |
| 369 | VRCA | Verrica Pharmaceuticals Inc. | 99.47M | -1.86% | 28,732 | 37.16M |
| 370 | INO | Inovio Pharmaceuticals, Inc. | 99.14M | -5.47% | 1,529,756 | 65.34K |
| 371 | BMEA | Biomea Fusion, Inc. | 99.05M | -1.44% | 883,337 | - |
| 372 | ALDX | Aldeyra Therapeutics, Inc. | 98.93M | -1.20% | 959,472 | - |
| 373 | OTLK | Outlook Therapeutics, Inc. | 98.33M | -3.49% | 18,460,117 | 333.14K |
| 374 | HYFT | MindWalk Holdings Corp. | 97.84M | 13.22% | 684,166 | 20.70M |
| 375 | RNTX | Rein Therapeutics Inc. | 95.83M | -3.74% | 298,944 | - |
| 376 | PYPD | PolyPid Ltd. | 93.38M | -3.94% | 197,220 | - |
| 377 | CUE | Cue Biopharma, Inc. | 93.17M | 18.93% | 119,323 | 32.73M |
| 378 | PMN | ProMIS Neurosciences, Inc. | 91.02M | -2.50% | 38,709 | - |
| 379 | PTHS | Pelthos Therapeutics Inc. | 90.37M | -0.76% | 6,183 | 27.70M |
| 380 | ICCC | ImmuCell Corporation | 89.93M | 2.79% | 38,970 | 29.93M |
| 381 | OKYO | OKYO Pharma Limited | 89.21M | -0.58% | 51,857 | - |
| 382 | FBIO | Fortress Biotech, Inc. | 88.03M | 3.11% | 516,897 | 66.16M |
| 383 | AARD | Aardvark Therapeutics, Inc. | 86.61M | -0.50% | 148,617 | - |
| 384 | RLYB | Rallybio Corporation | 85.85M | -3.79% | 183,814 | 858.00K |
| 385 | RANI | Rani Therapeutics Holdings, Inc. | 85.61M | -4.24% | 1,423,430 | 3.17M |
| 386 | ANIX | Anixa Biosciences, Inc. | 85.50M | -5.56% | 248,225 | - |
| 387 | HRTX | Heron Therapeutics, Inc. | 85.18M | -45.60% | 21,901,149 | 150.71M |
| 388 | ACET | Adicet Bio, Inc. | 85.16M | -7.63% | 170,762 | - |
| 389 | LONA | LeonaBio, Inc. | 84.73M | -2.91% | 20,604 | - |
| 390 | ATRA | Atara Biotherapeutics, Inc. | 84.27M | -3.70% | 56,219 | 23.14M |
| 391 | MAIA | MAIA Biotechnology, Inc. | 82.08M | 3.85% | 3,420,171 | - |
| 392 | LIXT | Lixte Biotechnology Holdings, Inc. | 81.67M | -2.50% | 303,954 | - |
| 393 | OSTX | OS Therapies Incorporated | 81.50M | -2.14% | 1,653,348 | - |
| 394 | NRXS | NeurAxis, Inc. | 80.65M | -4.50% | 239,440 | 4.28M |
| 395 | EXOZ | eXoZymes, Inc. | 80.55M | -1.76% | 5,394 | -700.00 |
| 396 | CSBR | Champions Oncology, Inc. | 79.50M | -1.97% | 2,385 | 57.95M |
| 397 | ANVS | Annovis Bio, Inc. | 79.13M | 2.20% | 1,494,360 | - |
| 398 | GANX | Gain Therapeutics, Inc. | 78.06M | -6.63% | 887,604 | - |
| 399 | XBIT | XBiotech Inc. | 73.78M | 1.68% | 69,360 | - |
| 400 | PLRX | Pliant Therapeutics, Inc. | 71.83M | -3.33% | 978,083 | - |
| 401 | MCRB | Seres Therapeutics, Inc. | 71.37M | -3.53% | 48,717 | 1.15M |
| 402 | ATHE | Alterity Therapeutics Limited | 70.35M | 0.10% | 3,634 | 4.43M |
| 403 | BYSI | BeyondSpring Inc. | 69.90M | -2.30% | 17,212 | 1.88M |
| 404 | FLNA | Filana Therapeutics, Inc. | 69.56M | -3.36% | 378,886 | - |
| 405 | ACRV | Acrivon Therapeutics, Inc. | 67.20M | 0.64% | 437,243 | - |
| 406 | MNOV | MediciNova, Inc. | 65.96M | -2.19% | 9,475 | 596.64K |
| 407 | PDSB | PDS Biotechnology Corporation | 64.75M | 1.75% | 1,086,628 | - |
| 408 | TCRX | TScan Therapeutics, Inc. | 64.04M | -2.97% | 476,215 | 9.14M |
| 409 | IBIO | iBio, Inc. | 63.61M | -6.88% | 1,135,861 | 300.00K |
| 410 | IMA | ImageneBio, Inc. | 63.50M | 2.93% | 45,915 | 800.00K |
| 411 | PMVP | PMV Pharmaceuticals, Inc. | 62.93M | -4.07% | 422,161 | - |
| 412 | ENTX | Entera Bio Ltd. | 61.53M | -1.57% | 131,857 | 42.00K |
| 413 | EDSA | Edesa Biotech, Inc. | 60.69M | 2.09% | 236,310 | - |
| 414 | INKT | MiNK Therapeutics, Inc. | 59.58M | -3.39% | 38,060 | - |
| 415 | IBO | Impact BioMedical Inc. | 56.16M | -6.01% | 62,113 | 39.00K |
| 416 | DWTX | Dogwood Therapeutics, Inc. | 56.11M | -1.18% | 27,715 | - |
| 417 | TIL | Instil Bio, Inc. | 55.00M | - | 12,449 | - |
| 418 | MREO | Mereo BioPharma Group plc | 54.17M | 10.27% | 7,723,071 | 500.00K |
| 419 | CING | Cingulate Inc. | 53.50M | 11.94% | 4,484,522 | - |
| 420 | RADX | Radiopharm Theranostics Limited | 53.21M | -2.78% | 21,619 | 10.86M |
| 421 | IMMP | Immutep Limited | 52.68M | 4.63% | 1,500,362 | 5.28M |
| 422 | HYPD | Hyperion DeFi, Inc. | 52.56M | -4.15% | 611,760 | 1.04M |
| 423 | GNTA | Genenta Science S.p.A. | 51.90M | 33.33% | 6,039,126 | - |
| 424 | ATYR | aTyr Pharma, Inc. | 50.99M | -4.87% | 1,344,424 | 190.00K |
| 425 | MGX | Metagenomi Therapeutics, Inc. | 50.64M | 2.67% | 202,810 | 22.33M |
| 426 | XLO | Xilio Therapeutics, Inc. | 49.06M | -0.61% | 26,753 | 53.48M |
| 427 | GOSS | Gossamer Bio, Inc. | 46.99M | 1.06% | 11,491,307 | 55.54M |
| 428 | ESLA | Estrella Immunopharma, Inc. | 46.48M | -2.68% | 6,466 | - |
| 429 | ACTU | Actuate Therapeutics, Inc. | 44.98M | -5.53% | 79,611 | - |
| 430 | KALA | KALA BIO, Inc. | 44.43M | 8.64% | 126,228 | - |
| 431 | NTRB | Nutriband Inc. | 43.15M | - | 6,881 | 2.04M |
| 432 | GRDX | GridAI Technologies Corp. | 43.05M | -4.85% | 121,232 | - |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 42.63M | -0.80% | 79,063 | - |
| 434 | LTRN | Lantern Pharma Inc. | 42.03M | 0.27% | 253,107 | - |
| 435 | ATOS | Atossa Therapeutics, Inc. | 41.77M | -5.09% | 77,565 | - |
| 436 | RNXT | RenovoRx, Inc. | 41.02M | -1.11% | 232,053 | 1.49M |
| 437 | GRCE | Grace Therapeutics, Inc. | 38.69M | -7.06% | 238,194 | - |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 38.03M | 3.39% | 82,879 | 90.00K |
| 439 | INMB | INmune Bio Inc. | 37.75M | 2.16% | 694,713 | 50.00K |
| 440 | VERU | Veru Inc. | 37.72M | -1.26% | 27,268 | 16.89M |
| 441 | PSTV | Plus Therapeutics, Inc. | 37.54M | -4.04% | 108,390 | 5.21M |
| 442 | NNVC | NanoViricides, Inc. | 36.22M | -5.36% | 281,755 | - |
| 443 | TVGN | Tevogen Bio Holdings Inc. | 35.47M | 5.22% | 19,062 | - |
| 444 | QNTM | Quantum BioPharma Ltd. | 33.96M | -2.67% | 607,937 | - |
| 445 | ALGS | Aligos Therapeutics, Inc. | 32.49M | -1.87% | 171,411 | 4.71M |
| 446 | BOLD | Boundless Bio, Inc. | 32.06M | -0.69% | 27,593 | - |
| 447 | DARE | Daré Bioscience, Inc. | 32.06M | -2.28% | 87,970 | 1.16M |
| 448 | ABVC | ABVC BioPharma, Inc. | 31.59M | -8.09% | 110,533 | 797.92K |
| 449 | LSTA | Lisata Therapeutics, Inc. | 31.43M | -2.79% | 158,198 | 170.00K |
| 450 | EVAX | Evaxion A/S | 31.28M | -3.85% | 42,069 | 7.53M |
| 451 | APLM | Apollomics, Inc. | 31.18M | -0.91% | 8,192 | 8.84M |
| 452 | SNTI | Senti Biosciences Holdings, Inc. | 30.64M | 0.36% | 263,454 | 38.00K |
| 453 | CELU | Celularity Inc. | 30.39M | -1.87% | 122,515 | 26.55M |
| 454 | TVRD | Tvardi Therapeutics, Inc. | 29.74M | -1.55% | 39,297 | - |
| 455 | IGC | IGC Pharma, Inc. | 28.65M | -1.69% | 382,650 | 1.11M |
| 456 | NRSN | NeuroSense Therapeutics Ltd. | 28.28M | -1.57% | 115,316 | - |
| 457 | CRVO | CervoMed Inc. | 27.78M | - | 27,593 | 2.09M |
| 458 | LITS | Lite Strategy, Inc. | 27.76M | -14.82% | 1,125,543 | - |
| 459 | KYNB | Kyntra Bio, Inc. | 27.69M | -0.87% | 2,686 | 7.44M |
| 460 | BRNS | Barinthus Biotherapeutics plc | 26.96M | -3.04% | 3,098 | 14.97M |
| 461 | NEUP | Neuphoria Therapeutics Inc. | 26.43M | -7.74% | 105,991 | -13.27K |
| 462 | PLRZ | Polyrizon Ltd. | 26.37M | -8.57% | 30,052 | - |
| 463 | SER | Serina Therapeutics, Inc. | 26.22M | -2.76% | 20,601 | 130.00K |
| 464 | ALLR | Allarity Therapeutics, Inc. | 26.13M | -1.74% | 164,658 | 345.00K |
| 465 | PLUR | Pluri Inc. | 25.52M | -1.87% | 23,161 | 1.08M |
| 466 | DYAI | Dyadic International, Inc. | 25.13M | -11.12% | 514,807 | 3.81M |
| 467 | SKYE | Skye Bioscience, Inc. | 25.07M | -6.08% | 352,134 | - |
| 468 | BCTX | BriaCell Therapeutics Corp. | 23.91M | -1.21% | 160,921 | - |
| 469 | MRKR | Marker Therapeutics, Inc. | 23.68M | -6.58% | 92,007 | 3.55M |
| 470 | PTN | Palatin Technologies, Inc. | 23.34M | -4.86% | 19,082 | 12.88M |
| 471 | VTGN | Vistagen Therapeutics, Inc. | 22.98M | -10.42% | 1,738,494 | 789.00K |
| 472 | VYNE | VYNE Therapeutics Inc. | 22.53M | -1.00% | 70,310 | 454.00K |
| 473 | LGVN | Longeveron Inc. | 22.25M | -1.30% | 208,798 | 1.22M |
| 474 | CLRB | Cellectar Biosciences, Inc. | 21.90M | -7.74% | 222,070 | - |
| 475 | SNSE | Sensei Biotherapeutics, Inc. | 21.61M | -18.65% | 60,458 | - |
| 476 | CVM | CEL-SCI Corporation | 21.59M | 0.68% | 177,717 | - |
| 477 | KTTA | Pasithea Therapeutics Corp. | 21.55M | -9.79% | 1,444,268 | - |
| 478 | TRAW | Traws Pharma, Inc. | 21.51M | -3.40% | 248,670 | 2.73M |
| 479 | HOWL | Werewolf Therapeutics, Inc. | 20.90M | -7.70% | 387,944 | 1.14M |
| 480 | CRIS | Curis, Inc. | 20.09M | -4.03% | 119,010 | 7.06M |
| 481 | XCUR | Exicure, Inc. | 19.82M | -6.61% | 19,842 | 500.00K |
| 482 | AEON | AEON Biopharma, Inc. | 19.74M | 0.03% | 18,798 | - |
| 483 | PASG | Passage Bio, Inc. | 18.91M | 0.77% | 25,206 | - |
| 484 | TPST | Tempest Therapeutics, Inc. | 18.86M | -9.31% | 263,774 | - |
| 485 | LPCN | Lipocine Inc. | 18.06M | -1.32% | 140,209 | 2.00M |
| 486 | NCEL | NewcelX Ltd. | 17.87M | -4.60% | 9,930 | - |
| 487 | QNCX | Quince Therapeutics, Inc. | 17.12M | -5.41% | 404,863 | - |
| 488 | GTBP | GT Biopharma, Inc. | 16.85M | 5.70% | 2,156,410 | - |
| 489 | AKTX | Akari Therapeutics, Plc | 16.75M | 8.94% | 263,840 | - |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 16.56M | -4.84% | 446,705 | 5.61M |
| 491 | HIND | Vyome Holdings, Inc. | 16.14M | -0.86% | 21,962 | 152.72K |
| 492 | JSPR | Jasper Therapeutics, Inc. | 15.43M | 3.20% | 2,851,007 | - |
| 493 | INAB | IN8bio, Inc. | 15.36M | -9.83% | 84,834 | - |
| 494 | LEXX | Lexaria Bioscience Corp. | 14.95M | -2.17% | 98,611 | 368.00K |
| 495 | BLRX | BioLineRx Ltd. | 14.72M | -2.59% | 21,969 | 1.40M |
| 496 | COCP | Cocrystal Pharma, Inc. | 14.48M | -5.41% | 184,763 | 225.00K |
| 497 | OSRH | OSR Holdings, Inc. | 14.28M | -5.15% | 2,057,521 | 2.63M |
| 498 | MLEC | Moolec Science SA | 14.21M | -0.29% | 26,275 | 7.83M |
| 499 | ICU | SeaStar Medical Holding Corporation | 14.11M | -3.02% | 59,395 | 1.44M |
| 500 | MTVA | MetaVia Inc. | 14.00M | -0.73% | 905,328 | - |